These cells might promote an inflammatory response; however, as smoking control subjects showed no sign of smoking-related respiratory diseases and no increases of IL-6 and IL-17A were found, the slight increase in TGF-β levels in the smoking group may be participating in regulation of the inflammatory response. This evidence concerns the gene IL17A and respiratory system disorder.